EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Examination of the effects of cannabidiol on menstrual-related symptoms.

Morgan L Ferretti iD, Taylor B Stanley, Erica N Peters, Marcel O Bonn-Miller, Jessica G Irons

Experimental and Clinical Psychopharmacology · 2024

DOI: 10.1037/pha0000709 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Experimental and Clinical Psychopharmacology, 2024. Verfasst von Morgan L Ferretti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Sciences, University of Arkansas. Hauptthemen laut MEDLINE: Cannabidiol. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: James Madison University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Some individuals attempt to alleviate menstrual-related symptoms (MRS) by using cannabis and report having expectations that cannabis can improve MRS; however, no study has examined the effect of cannabinoids on MRS. The present study is a pre-post, randomized, open-label trial that aimed to examine the effects of oral cannabidiol (CBD) isolate for alleviating MRS. Participants were assigned randomly to one of two open-label dosing groups of CBD softgels (160 mg twice a day, BID, n = 17; 320 mg BID, n = 16) and completed a 1-month baseline period. Following baseline, participants were instructed to consume CBD starting the first day they believed they experienced symptoms each month and to take their assigned dose daily for 5 consecutive days for three CBD-consumption months. We examined differences in MRS and related outcomes between baseline and 3 months of CBD consumption. Results revealed reductions (in both dosing groups) in MRS, irritability, anxiety, global impression of change, stress, and subjective severity scores when comparing baseline to all 3 months of CBD consumption. Depression scores did not change in either dosing group. Findings suggest that CBD may have the potential for managing MRS. Importantly, changes in symptoms appeared in the first month of CBD consumption and persisted over the 3 consumption months. Further research is warranted comparing the effects of CBD to placebo (a limitation of the study) and examining the potential to optimize CBD consumption for reducing MRS (e.g., combining CBD with terpenes; varying routes and timing of administration). (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolHumansFemaleAdultYoung AdultAnxietyMenstruation DisturbancesAdolescent

Substanzen

Cannabidiol

Autor:innen und Institutionen

  • Department of Psychological Sciences, University of Arkansas.
  • Department of Psychological Sciences, Auburn University.
  • Canopy Growth Corporation.
  • Charlotte's Web.
  • Department of Psychology, James Madison University.

ORCID-Profile: Morgan L Ferretti

Förderung

  • James Madison University

Zitieren

APA

Ferretti, M. L., Stanley, T. B., Peters, E. N., Bonn-Miller, M. O., & Irons, J. G. (2024). Examination of the effects of cannabidiol on menstrual-related symptoms. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000709

Vancouver

Ferretti ML, Stanley TB, Peters EN, Bonn-Miller MO, Irons JG. Examination of the effects of cannabidiol on menstrual-related symptoms. Experimental and Clinical Psychopharmacology. 2024. doi:10.1037/pha0000709

BibTeX
@article{Ferretti2024,
  author = {Ferretti, Morgan L and Stanley, Taylor B and Peters, Erica N and Bonn-Miller, Marcel O and Irons, Jessica G},
  title = {Examination of the effects of cannabidiol on menstrual-related symptoms},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2024},
  doi = {10.1037/pha0000709}
}
Kostenlos starten →